Button mushroom : a new therapeutic option for treating refractory Osteoarthritis?

Context

Osteoarthritis, particularly in active and athletic patients, presents a significant clinical challenge. When conventional treatments such as corticosteroid, hyaluronic acid, or PRP injections fail, what alternative therapeutic options can be considered?

Presentation by Prof. Thomas Neri

Prof. Thomas Neri will present a review of the literature on carboxymethyl-chitosan (CM-Chitosan), a molecule derived from button mushroom (agaricus bisporus), in managing osteoarthritis and athletic patients. He will also share his experience in using CM-Chitosan in his orthopedic surgeon practice.

Presentation by Dr. Benoit Bouthin

Dr. Benoît Bouthin will present the preliminary results of the currently ongoing clinical study with CM-Chitosan on refractory OA patients to corticosteroids, hyaluronic acid and PRP.

Discussion topics

✔ Patient profiles: athletic patients and active seniors (>50 years old) with treatment-resistant osteoarthritis.

✔ Case studies and clinical practice protocols: how to integrate this innovation into a comprehensive treatment strategy?

Practical information

📅 Date : Monday March 24, 2025

⏰ Time : 7:00 PM - 7:45 PM (CET)

💻 Format : Live webinar with interactive Q&A session

Target audience

Sports medicine physicians, orthopedic surgeons, rheumatologists, physiotherapists, and rehabilitation specialists interested in learning more about this innovative approach in sports medicine.

Why Attend?

This webinar offers a chance to explore how a biomaterial derived from the Paris mushroom could be integrated into the treatment of active and athletic osteoarthritis patients. Prof. Thomas Neri will share preliminary results, practical case studies, and engage in discussions about this emerging innovation.

📩 For any inquiries, contact Fabrice Letimier at fabrice.letimier@kiomedpharma.com